99mtc-ubiquicidin [29–41], a promising radiopharmaceutical to differentiate orthopedic implant infections from sterile inflammation

Authors

davood beiki research center for nuclear medicine, tehran university of medical sciences, tehran, iran.

gholamali yousefi research center for nuclear medicine, tehran university of medical sciences, tehran, iran.

babak fallahi research institute for nuclear medicine, tehran university of medical sciences, tehran, iran.

mohammad naghi tahmasebi department of orthopedic and trauma surgery, shariati hospital, tehran university of medical sciences, tehran, iran.

abstract

ubiquicidin (ubi) [29-41] is a synthetic cationic antimicrobial peptide that preferentially binds to bacterial cell membrane at the site of infection. we aimed to assess diagnostic value of 99mtc-ubi [29-41] as a radiopharmaceutical in differentiation of bacterial infection from sterile inflammation in suspected orthopedic implants. nine patients suspected for orthopedic implant infection, all males with the mean age of 41.6 ± 20.9 years, were studied. a dose of 10 mbq/kg (range : 555-740 mbq) 99mtc-ubi [29-41] was injected intravenously. a dynamic study followed by static whole body imaging at 30, 60 and 120 min post-radiotracer injection was acquired. periprosthetic tissue culture was considered the closest test to a gold standard for diagnosing infections and scintigraphic scans were categorized as true- or false-positive and true- or false-negative, considering the bacterial culture as the gold standard. no adverse reaction was observed during or after the radiotracer injection days. there were five true positive, four true negative and no false positive and false negative scans. sensitivity, specificity, positive predictive value (ppv) and negative predictive value (npv) were all calculated as 100%. we found a high diagnostic accuracy for 99mtc-ubi [29-41] scintigraphy in differentiation of bacterial infection from sterile inflammation in suspected orthopedic implants. therefore, 99mtc-ubi [29-41] scintigraphy might be potentially recommended as a safe and promising imaging modality in these settings. however, further studies on a larger number of patients and different pathologies are still needed.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

99mtc-Ubiquicidin [29–41], a Promising Radiopharmaceutical to Differentiate Orthopedic Implant Infections from Sterile Inflammation

Ubiquicidin (UBI) [29-41] is a synthetic cationic antimicrobial peptide that preferentially binds to bacterial cell membrane at the site of infection. We aimed to assess diagnostic value of 99mTc-UBI [29-41] as a radiopharmaceutical in differentiation of bacterial infection from sterile inflammation in suspected orthopedic implants. Nine patients suspected for orthopedic implant infection, all ...

full text

99mtc-Ubiquicidin [29–41], a Promising Radiopharmaceutical to Differentiate Orthopedic Implant Infections from Sterile Inflammation

Ubiquicidin (UBI) [29-41] is a synthetic cationic antimicrobial peptide that preferentially binds to bacterial cell membrane at the site of infection. We aimed to assess diagnostic value of 99mTc-UBI [29-41] as a radiopharmaceutical in differentiation of bacterial infection from sterile inflammation in suspected orthopedic implants. Nine patients suspected for orthopedic implant infection, all ...

full text

99mtc-Ubiquicidin [29–41], a Promising Radiopharmaceutical to Differentiate Orthopedic Implant Infections from Sterile Inflammation

Ubiquicidin (UBI) [29-41] is a synthetic cationic antimicrobial peptide that preferentially binds to bacterial cell membrane at the site of infection. We aimed to assess diagnostic value of (99m)Tc-UBI [29-41] as a radiopharmaceutical in differentiation of bacterial infection from sterile inflammation in suspected orthopedic implants. Nine patients suspected for orthopedic implant infection, al...

full text

Evaluation of 99mTc-Ubiquicidin 29-41 scintigraphyin in differentiation of bacterial infection from sterile inflammationin diabetic foot

  Introduction: Ubiquicidin (UBI) 29-41 is a synthetic antimicrobial peptide that binds with the microbial cell membrane at the location of infection. This study was conducted to evaluate its probable efficacy as an infection-imaging agent with potential to differentiate bacterial infection from sterile inflammation in humans. Methods: Fifteen diabetic foot patients ...

full text

Efficacy of 99mTc-Ciprofloxacin and 67Ga-Citrate scintigraphy to discriminate infection foci induced by Staphylococcus aureus from sterile inflammation induced by Carrageenan in rat

Introduction: This study was launched to evaluate the sensitivity and specificity of 99mTc-Ciprofloxacin to distinguish infection foci induced by staphylococcus aureus and inflammation lesions induced by carrageenan in the rat foot in comparison with 67Ga-Citrate scintigraphy. Methods: The labeling and quality control of 99mTc-Ciprofloxacin kits have been perfo...

full text

evaluation of 99mtc-ubiquicidin 29-41 scintigraphyin in differentiation of bacterial infection from sterile inflammationin diabetic foot

introduction: ubiquicidin (ubi) 29-41 is a synthetic antimicrobial peptide that binds with the microbial cell membrane at the location of infection. this study was conducted to evaluate its probable efficacy as an infection-imaging agent with potential to differentiate bacterial infection from sterile inflammation in humans. methods: fifteen diabetic foot patients (10 males and 5 females) with...

full text

My Resources

Save resource for easier access later


Journal title:
iranian journal of pharmaceutical research

جلد ۱۲، شماره ۲، صفحات ۳۴۷-۳۵۳

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023